Chanelle

Osteopen 100mg/ml solution for injection

Name: Osteopen 100mg/ml solution for injection
Availability: InStock

per bottle £59.69

Osteopen is used for the treatment of lameness and pain associated with degenerative joint disease/osteoarthritis (non-infectious arthrosis) in dogs and horses.

Legal Category POM-V

This product requires a valid veterinary prescription for purchase.

Prescriptions

I understand a valid veterinary prescription is required for this prescription-only medicine *
I will provide my prescription by: *
Email prescription *

Please e-mail your prescription to [email protected]
Post prescription *

Please send to: Dr Nicola Endersby MRCVS, Cura, 4 Saxon Court, Bishop Auckland DL14 7UA

Vet will send directly *

Please ask your vet to e-mail your prescription to [email protected] with your name and order number as a reference. (You will receive your order number once you have completed your purchase) Please confirm your Vet Practice name below

Your vet practice: *
Prescription *

Please upload your prescription for this product.Max file size: 25 MBPermitted file types: jpg jpeg jpe gif png pdf
Animal name(s) *

Product total

Options total

Grand total

View POM Delivery & Returns

Secure Checkout with

Accredited Retailer

Osteopen is a semi-synthetic polymer with anti-inflammatory properties, which benefit the cartilage and other components of synovial joints.

Use of the product on an ongoing basis influences the underlying disease processes occurring in arthritis, reducing pain and helping regenerate damaged joint components.

Dosage and administration

3 mg pentosan polysulphate sodium / kg bodyweight (equivalent to 0.3 ml/10kg bodyweight) on four occasions, with an interval of 5-7 days.

Administer by aseptic subcutaneous injection only. An appropriately graduated syringe must be used to allow accurate administration of the required dose volume. This is particularly important when injecting small volumes.

To establish the appropriate dosage, the weight of the individual animal should be determined prior to administering the veterinary medicinal product.

Contra-indications, warnings, etc

•Do not use in the treatment of septic arthritis. In this case, appropriate antimicrobial therapy should be instigated.
•Do not use in dogs with advanced liver or kidney impairment, or evidence of infection.
•Do not use in known cases of hypersensitivity to the active substance or to any of the excipients.
•Do not use in the skeletally immature dog (i.e. dogs whose long bone growth plates have not closed).
•As pentosan polysulphate has an anticoagulant effect, do not use in dogs with blood disorders, coagulation disorders, bleeding, trauma or malignancy (especially haemangiosarcoma) or during the peri-operative period within 6 – 8 hours of surgery..
•Do not use in arthritides of immunological origin (e.g. rheumatoid arthritis).

A clinical effect may not be observed until after the second injection of osteopen in the course of treatment.

You can find the SPC for this product here

Product Description

Osteopen is a semi-synthetic polymer with anti-inflammatory properties, which benefit the cartilage and other components of synovial joints.

Use of the product on an ongoing basis influences the underlying disease processes occurring in arthritis, reducing pain and helping regenerate damaged joint components.

Dosage and administration

3 mg pentosan polysulphate sodium / kg bodyweight (equivalent to 0.3 ml/10kg bodyweight) on four occasions, with an interval of 5-7 days.
Administer by aseptic subcutaneous injection only. An appropriately graduated syringe must be used to allow accurate administration of the required dose volume. This is particularly important when injecting small volumes.
To establish the appropriate dosage, the weight of the individual animal should be determined prior to administering the veterinary medicinal product.

Contra-indications, warnings, etc

•Do not use in the treatment of septic arthritis. In this case, appropriate antimicrobial therapy should be instigated.
•Do not use in dogs with advanced liver or kidney impairment, or evidence of infection.
•Do not use in known cases of hypersensitivity to the active substance or to any of the excipients.
•Do not use in the skeletally immature dog (i.e. dogs whose long bone growth plates have not closed).
•As pentosan polysulphate has an anticoagulant effect, do not use in dogs with blood disorders, coagulation disorders, bleeding, trauma or malignancy (especially haemangiosarcoma) or during the peri-operative period within 6 – 8 hours of surgery..
•Do not use in arthritides of immunological origin (e.g. rheumatoid arthritis).

A clinical effect may not be observed until after the second injection of osteopen in the course of treatment.

You can find the SPC for this product here